DBpedia – Linked Data Fragments

Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Jeffery_W._Kelly> ?p ?o }

• Jeffery_W._Kelly abstract "Jeffery W. Kelly (born August 23, 1960 in Medina, New York) is the former Dean of Graduate Studies (2000-2008) and Vice President of Academic Affairs (2000-2006) and currently is the Chairman of Molecular and Experimental Medicine and the Lita Annenberg Hazen Professor of Chemistry within the Skaggs Institute of Chemical Biology at The Scripps Research Institute in La Jolla, California. His research focuses on understanding protein folding, misfolding and aggregation and on developing both chemical and biological strategies to ameliorate diseases caused by protein misfolding and/or aggregation.Kelly received his Ph.D. in organic chemistry from the University of North Carolina at Chapel Hill (1986) and performed post-doctoral research at The Rockefeller University (1986–89). His research focuses on the chemistry and biology of protein homeostasis or proteostasis. Besides studying the structural and energetic basis behind protein folding, his laboratory also studies the etiology of neurodegenerative diseases linked to protein aggregation, including Alzheimer's disease, Parkinson's Disease, and the familial gelsolin and transthyretin-based amyloidoses–publishing over 300 peer-reviewed papers in this area to date (h-index = 78). He has also provided insight into genetic diseases associated with loss of protein function, such as lysosomal storage diseases.Kelly has cofounded three biotechnology companies, FoldRx Pharmaceuticals (with Susan Lindquist), now owned by Pfizer, Proteostasis Therapeutics, Inc. (with Andrew Dillin and Richard Morimoto) (a private corporation) and Misfolding Diagnostics (with Xin Jiang and Justin Chapman; a private corporation). The Kelly laboratory discovered the first regulatory agency-approved drug that slows the progression of a human amyloid disease using a structure-based design approach. This drug, now called Tafamidis or Vyndaqel, slowed the progression of familial amyloid polyneuropathy in an 18 month placebo controlled trial and in an 12 month extension study sponsored by FoldRx Pharmaceuticals (acquired by Pfizer in 2010). Vyndaqel or Tafamidis was approved for the treatment of Familial amyloid Polyneuropathy by the European Medicines Agency in late 2011 and by the Japanese Pharmaceuticals and Medical Devices Agency in 2013. A second statistically significant clinical trial with the repurposed Merck Non steroidal anti-inflammatory drug, diflunisal discovered by Kelly to kinetically stabilize TTR, confirms the validity of the kinetic stabilizer mechanism to ameliorate the TTR amyloidoses. Collectively, the tafamidis and diflunisal data provide compelling pharmacologic evidence for the amyloid hypothesis, the idea that active transthyretin aggregation causes the loss of post-mitotic tissue in this degenerative amyloid disease. Moreover, these data validate transthyretin as a key drug target to stop the progression of diseases linked to transthyretin aggregation.In addition to discovering the first drug that slows the progression of a human amyloid disease, the Kelly Laboratory is credited with demonstrating that transthyretin conformational changes alone are sufficient for amyloidogenesis, discovering the first example of functional amyloid in mammals, making major contributions toward understanding β-sheet folding, discovering the "enhanced aromatic sequon"–sequences that are more efficiently glycosylated by cells and stabilize the native state of proteins that they are incorporated into as a consequence of aromatic side chain–N-glycan interactions and was corresponding author on and contributed some of the key experimental data demonstrating that altering cellular protein homeostasis or proteostasis capacity has the potential to alleviate protein misfolding and aggregation diseases.Kelly has won numerous awards including the Biopolymers Murray Goodman Memorial Prize, 2012; The American Chemical Society, Ralph F. Hirschmann Award in Peptide Chemistry, 2012; The Protein Society Emil T. Kaiser Award, 2011; The American Peptide Society Rao Makineni Lectureship (Award), 2011; The American Peptide Society Vincent du Vigneaud Award, 2008; National Institutes of Health Merit Award, 2006; American Chemical Society Arthur C. Cope Scholar Award, 2001; SUNY at Fredonia Alumni Distinguished Achievement Award, 2000; SUNY at Fredonia Chemistry Dept. Alumni Award, 2000; The Protein Society-Dupont Young Investigator Award, 1999; The Biophysical Society National Lecturer (Award), 1999; Texas A&M Univ. Honors Program Teacher / Scholar Award, 1994 and the Searle Scholar Award, 1991.".
• Jeffery_W._Kelly birthDate "1960-08-23".
• Jeffery_W._Kelly birthYear "1960".
• Jeffery_W._Kelly wikiPageExternalLink kelly.
• Jeffery_W._Kelly wikiPageID "17000460".
• Jeffery_W._Kelly wikiPageLength "12717".
• Jeffery_W._Kelly wikiPageOutDegree "21".
• Jeffery_W._Kelly wikiPageRevisionID "663133715".
• Jeffery_W._Kelly wikiPageWikiLink Alzheimers.
• Jeffery_W._Kelly wikiPageWikiLink Alzheimers_disease.
• Jeffery_W._Kelly wikiPageWikiLink Category:1960_births.
• Jeffery_W._Kelly wikiPageWikiLink Category:American_chemists.
• Jeffery_W._Kelly wikiPageWikiLink Category:Living_people.
• Jeffery_W._Kelly wikiPageWikiLink Category:People_from_Medina,_New_York.
• Jeffery_W._Kelly wikiPageWikiLink Category:The_Scripps_Research_Institute_faculty.
• Jeffery_W._Kelly wikiPageWikiLink La_Jolla.
• Jeffery_W._Kelly wikiPageWikiLink La_Jolla,_California.
• Jeffery_W._Kelly wikiPageWikiLink Lysosomal_storage_disease.
• Jeffery_W._Kelly wikiPageWikiLink Lysosomal_storage_diseases.
• Jeffery_W._Kelly wikiPageWikiLink Medina,_New_York.
• Jeffery_W._Kelly wikiPageWikiLink Neurodegeneration.
• Jeffery_W._Kelly wikiPageWikiLink Neurodegenerative_disease.
• Jeffery_W._Kelly wikiPageWikiLink Parkinsons.
• Jeffery_W._Kelly wikiPageWikiLink Parkinsons_disease.
• Jeffery_W._Kelly wikiPageWikiLink Protein_folding.
• Jeffery_W._Kelly wikiPageWikiLink Proteostasis.
• Jeffery_W._Kelly wikiPageWikiLink Richard_I._Morimoto.
• Jeffery_W._Kelly wikiPageWikiLink Richard_Morimoto.
• Jeffery_W._Kelly wikiPageWikiLink Rockefeller_University.
• Jeffery_W._Kelly wikiPageWikiLink Scripps_Research_Institute.
• Jeffery_W._Kelly wikiPageWikiLink Searle_Scholar.
• Jeffery_W._Kelly wikiPageWikiLink Searle_Scholars_Program.
• Jeffery_W._Kelly wikiPageWikiLink Susan_Lindquist.
• Jeffery_W._Kelly wikiPageWikiLink Tafamidis.
• Jeffery_W._Kelly wikiPageWikiLink University_of_North_Carolina.
• Jeffery_W._Kelly wikiPageWikiLinkText "Jeffery W. Kelly".
• Jeffery_W._Kelly dateOfBirth "1960-08-23".
• Jeffery_W._Kelly hasPhotoCollection Jeffery_W._Kelly.
• Jeffery_W._Kelly name "Kelly, Jeffery W.".
• Jeffery_W._Kelly placeOfBirth "Medina, New York".
• Jeffery_W._Kelly shortDescription "American chemist".
• Jeffery_W._Kelly wikiPageUsesTemplate Template:Authority_control.
• Jeffery_W._Kelly wikiPageUsesTemplate Template:BLP_sources.
• Jeffery_W._Kelly wikiPageUsesTemplate Template:Persondata.
• Jeffery_W._Kelly wikiPageUsesTemplate Template:Reflist.
• Jeffery_W._Kelly description "American chemist".
• Jeffery_W._Kelly description "American chemist".
• Jeffery_W._Kelly subject Category:1960_births.
• Jeffery_W._Kelly subject Category:American_chemists.
• Jeffery_W._Kelly subject Category:Living_people.
• Jeffery_W._Kelly subject Category:People_from_Medina,_New_York.
• Jeffery_W._Kelly subject Category:The_Scripps_Research_Institute_faculty.
• Jeffery_W._Kelly hypernym Dean.
• Jeffery_W._Kelly type Agent.
• Jeffery_W._Kelly type Article.
• Jeffery_W._Kelly type List.
• Jeffery_W._Kelly type Person.
• Jeffery_W._Kelly type Scientist.
• Jeffery_W._Kelly type Article.
• Jeffery_W._Kelly type List.
• Jeffery_W._Kelly type Scientist.
• Jeffery_W._Kelly type Person.
• Jeffery_W._Kelly type Agent.
• Jeffery_W._Kelly type NaturalPerson.
• Jeffery_W._Kelly type Thing.
• Jeffery_W._Kelly type Q215627.
• Jeffery_W._Kelly type Q5.
• Jeffery_W._Kelly type Person.
• Jeffery_W._Kelly comment "Jeffery W. Kelly (born August 23, 1960 in Medina, New York) is the former Dean of Graduate Studies (2000-2008) and Vice President of Academic Affairs (2000-2006) and currently is the Chairman of Molecular and Experimental Medicine and the Lita Annenberg Hazen Professor of Chemistry within the Skaggs Institute of Chemical Biology at The Scripps Research Institute in La Jolla, California.".
• Jeffery_W._Kelly label "Jeffery W. Kelly".
• Jeffery_W._Kelly sameAs Jeffery_Kelly.
• Jeffery_W._Kelly sameAs m.04153ht.
• Jeffery_W._Kelly sameAs Q6175781.
• Jeffery_W._Kelly sameAs Q6175781.
• Jeffery_W._Kelly wasDerivedFrom Jeffery_W._Kelly?oldid=663133715.
• Jeffery_W._Kelly givenName "Jeffery W.".
• Jeffery_W._Kelly isPrimaryTopicOf Jeffery_W._Kelly.
• Jeffery_W._Kelly name "Jeffery W. Kelly".
• Jeffery_W._Kelly name "Kelly, Jeffery W.".
• Jeffery_W._Kelly surname "Kelly".